Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

Renapharma AB

Closing information (x1000 EUR)

Closing information 2024/12 2023/12 2022/12
Turnover 3,102 Less Arrow 2,722 Less Arrow 2,710
Financial expenses 0 More Arrow 7 Less Arrow 3
Earnings before taxes 466 More Arrow 595 More Arrow 663
EBITDA 685 Less Arrow 646 More Arrow 710
Total assets 3,598 More Arrow 3,989 Less Arrow 3,337
Current assets 1,680 More Arrow 1,954 Less Arrow 1,747
Current liabilities 362 More Arrow 871 Less Arrow 693
Equity capital 2,717 Less Arrow 2,388 Less Arrow 1,788
- share capital 9 Equal arrow 9 Equal arrow 9
Employees (average) 4 Equal arrow 4 Equal arrow 4

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 75.5% Less Arrow 59.9% Less Arrow 53.6%
Turnover per employee 776 Less Arrow 680 Less Arrow 678
Profit as a percentage of turnover 15.0% More Arrow 21.9% More Arrow 24.5%
Return on assets (ROA) 13.0% More Arrow 15.1% More Arrow 20.0%
Current ratio 464.1% Less Arrow 224.3% More Arrow 252.1%
Return on equity (ROE) 17.2% More Arrow 24.9% More Arrow 37.1%
Change turnover 473 Less Arrow 4 More Arrow 634
Change turnover % 18% Less Arrow 0% More Arrow 31%
Chg. No. of employees 0 Equal arrow 0 More Arrow 1
Chg. No. of employees % 0% Equal arrow 0% More Arrow 33%

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.